- Home
- VMEO vs RLAY Comparison
VMEO vs RLAY Comparison
Compare VMEO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMEO
- RLAY
- Stock Information
- Founded
- VMEO 2004
- RLAY 2015
- Country
- VMEO United States
- RLAY United States
- Employees
- VMEO N/A
- RLAY N/A
- Industry
- VMEO Computer Software: Prepackaged Software
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VMEO Technology
- RLAY Health Care
- Exchange
- VMEO Nasdaq
- RLAY Nasdaq
- Market Cap
- VMEO 1.1B
- RLAY 1.1B
- IPO Year
- VMEO N/A
- RLAY 2020
- Fundamental
- Price
- VMEO $6.46
- RLAY $4.45
- Analyst Decision
- VMEO Buy
- RLAY Strong Buy
- Analyst Count
- VMEO 4
- RLAY 10
- Target Price
- VMEO $7.50
- RLAY $20.11
- AVG Volume (30 Days)
- VMEO 1.4M
- RLAY 2.7M
- Earning Date
- VMEO 11-04-2024
- RLAY 11-06-2024
- Dividend Yield
- VMEO N/A
- RLAY N/A
- EPS Growth
- VMEO 290.90
- RLAY N/A
- EPS
- VMEO 0.20
- RLAY N/A
- Revenue
- VMEO $419,394,000.00
- RLAY $10,006,000.00
- Revenue This Year
- VMEO $1.32
- RLAY N/A
- Revenue Next Year
- VMEO $2.07
- RLAY N/A
- P/E Ratio
- VMEO $32.68
- RLAY N/A
- Revenue Growth
- VMEO 0.52
- RLAY N/A
- 52 Week Low
- VMEO $3.43
- RLAY $4.18
- 52 Week High
- VMEO $7.90
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- VMEO 45.92
- RLAY 39.07
- Support Level
- VMEO $6.77
- RLAY $4.41
- Resistance Level
- VMEO $7.06
- RLAY $5.03
- Average True Range (ATR)
- VMEO 0.31
- RLAY 0.31
- MACD
- VMEO -0.08
- RLAY 0.05
- Stochastic Oscillator
- VMEO 5.26
- RLAY 20.65
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. Its comprehensive and cloud-based tools empower its users to create, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).